In vitro expression analysis of collagen biosynthesis and assembly

Journal of Biochemical and Biophysical Methods

Volumn 36, Issue 1, 1997, Pages 11-29

  Chan, Danny ^a   Lamandé, Shireen R ^a   McQuillan, David J ^b   Bateman, John F ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Albert B Alkek Inst Biosci T   (United States)

Author keywords

Cell free translation; Collagen; In vitro expression; Protein assembly; Transfection; Vaccinia

Indexed keywords

COLLAGEN; COMPLEMENTARY DNA; MESSENGER RNA; RECOMBINANT PROTEIN; RNA POLYMERASE;

ARTICLE; BACTERIOPHAGE T7; BIOSYNTHESIS; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; CELLS, CULTURED; COLLAGEN; HUMANS; MAMMALS; MUTATION; PROTEIN BIOSYNTHESIS; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0031409866     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(97)00042-0     Document Type: Article

References (53)

1. Weiss JB, Ayad S. An introduction to collagen. In: Weiss JB, Jayson MIV, editors. Collagen in health and disease. Edinburgh: Churchill Livingstone, 1982:1-27.
2. Burgeson R.E. New collagens, new concepts. Annu. Rev. Cell Biol. 4:1988;551-577.
3. Vuorio E., de Crombrugghe B. The family of collagen genes. Annu. Rev. Biochem. 59:1990;837-872.
4. van der Rest M., Garrone R. Collagen family of proteins. FASEB J. 5:1991;2814-2823.
5. Kielty CM, Hopkinson I, Grant ME. Collagen. The collagen family: structure, assembly, and organization in the extracellular matrix. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders. Molecular, genetic, and medical aspects. New York: Wiley-Liss, 1993:103-147.
6. Bateman JF, Lamandé SR, Ramshaw JAM, Collagen Superfamily. In: Comper WD, editor. Extracellular matrix.Amsterdam: Harwood, 1996:22-67.
7. Dion A.S., Myers J.C. COOH-terminal propeptides of the major human procollagens. Structural, functional and genetic comparisons. J. Mol. Biol. 193:1987;127-143.
8. Brass A., Kadler K.E., Thomas J.T., Grant M.E., Boot-Handford R.P. The fibrillar collagens, collagen VIII, collagen X and C1q complement proteins share a similar domain in their C-terminal non-collagenous regions. FEBS Lett. 303:1992;126-128.
9. Bateman J.F., Lamandé S.R., Dahl H.H., Chan D., Mascara T., Cole W.G. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal proα1(I) propeptide of type I collagen in osteogenesis imperfecta. J. Biol. Chem. 264:1989;10960-10964.
10. Byers P.H. Inherited disorders of collagen gene structure and expression. Am. J. Med. Genet. 34:1989;72-80.
11. Prockop D.J., Constantinou C.D., Dombrowski K.E., Hojima Y., Kadler K.E., Kuivaniemi H., Tromp G., Vogel B.E. Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue. Am. J. Med. Genet. 34:1989;60-67.
12. Byers PH. Osteogenesis imperfecta. In: Royce PM Steinmann B, editors. Connective tissue and its heritable disorders. Molecular, genetic, and medical aspects, New York: Wiley-Liss, 1993:317-350.
13. Chessler S.D., Wallis G.A., Byers P.H. Mutations in the carboxyl-terminal propeptide of the proα1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta. J. Biol. Chem. 268:1993;18218-18225.
14. Lamandé S.R., Chessler S.D., Golub S.B., Byers P.H., Chan D., Cole W.G., Sillence D.O., Bateman J.F. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the proα1(I) chain carboxyl-terminal propeptide which impair subunit assembly. J. Biol. Chem. 270:1995;8642-8649.
15. Stacey A., Bateman J., Choi T., Mascara T., Cole W., Jaenisch R. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-α1(I) collagen gene. Nature. 332:1988;131-136.
16. Wu H., Byrne M.H., Stacey A., Goldring M.B., Birkhead J.R., Jaenisch R., Krane S.M. Generation of collagenase-resistant collagen by site-directed mutagenesis of murine proα1(I) collagen gene. Proc. Natl. Acad. Sci. USA. 87:1990;5888-5892.
17. Lee S.-T., Lee S., Peters D.P., Hoffman G.G., Stacey A., Greenspan D.S. Deletion of the pro-α1(I) N-propeptide affects secretion of type I collagen in chinese hamster lung cells but not in Mov-13 mouse cells. J. Biol. Chem. 267:1992;24126-24133.
18. Lamandé S.R., Bateman J.F. The type I collagen proα1(I) COOH-terminal propeptide N-linked oligosaccharide. Functional analysis by site-directed mutagenesis. J. Biol. Chem. 270:1995;17858-17865.
19. Chan D., Cole W.G., Rogers J.G., Bateman J.F. Type X collagen multimer assembly in vitro is prevented by a Gly618 to Val mutation in the α1(X) NC1 domain resulting in Schmid metaphyseal chondrodysplasia. J. Biol. Chem. 270:1995;4558-4562.
20. Chan D., Weng Y.M., Hocking A.M., Golub S., McQuillan D.J., Bateman J.F. Site-directed mutagenesis of human type X collagen. Expression of α1(X) NC1, NC2, and helical mutations in vitro and in transfected cells. J. Biol. Chem. 271:1996;13566-13572.
21. Ouellette L.A., Paglia L.M., Martin G.R. Characterization of the cell free translation products from types I and II procollagen mRNAs. Coll. Rel. Res. 1:1981;327-335.
22. Monson J.M. Assembly of procollagen mRNA translation products into pepsin-resistant structures. Coll. Rel. Res. 3:1983;1-12.
23. Cheah K.S., Grant M.E., Jackson D.S. Translation of type II procollagen mRNA and hydroxylation of the cell-free product. Biochem. Biophys. Res. Commun. 91:1979;1025-1031.
24. Middleton R.B., Bulleid N.J. Reconstitution of the folding pathway of collagen in a cell-free system: formation of correctly aligned and hydroxylated triple helices. Biochem. J. 296:1993;511-517.
25. Austen B.M., Hermon-Taylor J., Kaderbhai M.A., Ridd D.H. Design and synthesis of a consensus signal sequence that inhibits protein translocation into rough microsomal vesicles. Biochem. J. 224:1984;317-325.
26. Wilson R., Allen A.J., Oliver J., Brookman J.L., High S., Bulleid N.J. The translocation, folding, assembly and redox-dependent degradation of secretory and membrane proteins in semi-permeabilized mammalian cells. Biochem. J. 307:1995;679-687.
27. Bulleid N.J., Wilson R., Lees J.F. Type-III procollagen assembly in semi-intact cells: chain association, nucleation and triple-helix folding do not require formation of inter-chain disulphide bonds but triple-helix nucleation does require hydroxylation. Biochem. J. 317:1996;195-202.
28. Lees J.F., Tasab M., Bulleid N.J. Identification of the molecular recognition sequence which determines the type-specific assembly of procollagen. EMBO J. 16:1997;908-916.
29. Hocking A.M., Strugnell R.A., Ramamurthy P., McQuillan D.J. Eukaryotic expression of recombinant biglycan. Post-translational processing and the importance of secondary structure for biological activity. J. Biol. Chem. 271:1996;19571-19577.
30. Fuerst T.R., Niles E.G., Studier F.W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
31. Moss B., Elroy-Stein O., Mizukami T., Alexander W.A., Fuerst T.R. Product review. New mammalian expression vectors. Nature. 348:1990;91-92.
32. Stacey A., Mulligan R., Jaenisch R. Rescue of type I collagen-deficient phenotype by retroviral-vector-mediated transfer of human α1(I) collagen gene into Mov-13 cells. J. Virology. 61:1987;2549-2554.
33. Lamandé S.R., Bateman J.F. A type I collagen reporter gene construct for protein engineering studies. Functional equivalence of transfected reporter COL1A1 and endogenous gene products during biosynthesis and in vitro extracellular matrix accumulation. Biochem. J. 293:1993;387-394.
34. Cullen B.R. Use of eukaryotic expression technology in the functional analysis of cloned genes. Meth. Enzymol. 152:1987;684-704.
35. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, 1989.
36. Schnieke A., Dziadek M., Bateman J., Mascara T., Harbers K., Gelinas R., Jaenisch R. Introduction of the human proα1(I) gene into proα1(I)-deficient Mov-13 mouse cells leads to formation of functional mouse-human hybrid type I collagen. Proc. Natl. Acad. Sci. USA. 84:1987;764-768.
37. Olsen A.S., Geddis A.E., Prockop D.J. High levels of expression of a minigene version of the human proα1(I) collagen gene in stably transfected mouse fibroblasts. J. Biol. Chem. 266:1991;1117-1121.
38. Geddis A.E., Prockop D.J. Expression of human COL1A1 gene in stably transfected HT1080 cells: the production of a thermostable homotrimer of type I collagen in a recombinant system. Matrix. 13:1993;399-405.
39. Fertala A., Sieron A.L., Ganguly A., Li S.W., Ala-Kokko L., Anumula K.R., Prockop D.J. Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080). Biochem. J. 298:1994;31-37.
40. Ala-Kokko L., Hyland J., Smith C., Kivirikko K.I., Jimenez S.A., Prockop D.J. Expression of a human cartilage procollagen gene (COL2A1) in mouse 3T3 cells. J. Biol. Chem. 266:1991;14175-14178.
41. Colombatti A., Bonaldo P., Bucciotti F. Stable expression of chicken type-VI collagen α1, α2 and α3 cDNAs in murine NIH/3T3 cells. Eur. J. Biochem. 209:1992;785-792.
42. Colombatti A., Mucignat M.T., Bonaldo P. Secretion and matrix assembly of recombinant type VI collagen. J. Biol. Chem. 270:1995;13105-13111.
43. Specks U., Mayer U., Nischt R., Spissinger T., Mann K., Timpl R., Engel J., Chu M.-L. Structure of recombinant N-terminal globule of type VI collagen a3 chain and its binding to heparin and hyaluronan. EMBO J. 11:1992;4281-4290.
44. Tillet E., Wiedemann H., Golbik R., Pan T.-C., Zhang R.-Z., Mann K., Chu M.-L., Timpl R. Recombinant expression and structural and binding properties of α1(VI) and α2(VI) chains of human collagen type VI. Eur. J. Biochem. 221:1994;177-185.
45. Southern P.J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early promoter. J. Mol. Appl. Genet. 1:1982;327-341.
46. Lamandé SR, Bateman JF. In vitro expression of type I collagen mutations produced by protein engineering. In: Slavkin H, Price P, editors. Chemistry and biology of mineralized tissues, Amsterdam: Elsevier Science Publishers, 1992:409-416.
47. Wise R.J., Orkin S.H., Collins T. Aberrant expression of platelet-derived growth factor A-chain cDNAs due to cryptic splicing of RNA transcripts in COS-1 cells. Nucleic Acids Res. 17:1989;6591-6601.
48. de Mars M., Cizdziel P.E., Murphy E.C. Activation of cryptic splice sites in murine sarcoma virus-124 mutants. J. Virol. 64:1990;5260-5269.
49. Huang M.T., Gorman C.M. The simian virus 40 small-t intron, present in many common expression vectors, leads to aberrant splicing. Mol. Cell. Biol. 10:1990;1805-1810.
50. Wiederkehr A., Caroni P. Widely used enhancer of eukaryotic expression vectors is strongly and differentially regulated in fibroblast, myoblast, and teratocarcinoma cell lines. Exp. Cell Res. 219:1995;664-670.
51. Schnieke A., Harbers K., Jaenisch R. Embryonic lethal mutation in mice induced by retrovirus insertion into the α1(I) collagen gene. Nature. 304:1983;315-320.
52. Harbers K., Kuehn M., Delius H., Jaenisch R. Retrovirus insertion inactivates mouse α1(I) collagen gene by blocking initiation of transcription. Proc. Natl. Acad. Sci. USA. 81:1984;1504-1508.
53. Lamandé S.R., Bateman J.F. A mouse 3T6 fibroblast cell culture model for the study of normal and protein-engineered collagen synthesis and deposition into the extracellular matrix. Matrix. 13:1993;323-330.